HRT May Shield Women's Brains from Inflammation and Alzheimer's Risk

New research highlights the benefits of hormone replacement therapy (HRT) for women experiencing menopause. The treatment may help prevent brain inflammation and related diseases, including Alzheimer’s and multiple sclerosis. Scientists have also uncovered a genetic link that explains why women face higher risks of such conditions. A study from UCLA found that brain inflammation is tied to diseases like Alzheimer’s and multiple sclerosis. Women, who carry two X chromosomes, are more vulnerable due to a gene called KDM6A. When researchers deactivated this gene in mice, symptoms resembling multiple sclerosis improved.

Menopause plays a key role in inflammation because estrogen, which has anti-inflammatory effects, declines during this stage. Without enough estrogen, women become more susceptible to inflammation-based diseases. HRT can help by restoring hormone levels, easing symptoms like brain fog, mood swings, and joint pain. Beyond brain health, HRT offers additional protections. It supports bone strength, heart health, and may lower the risk of long-term disorders such as dementia. Better sleep, another benefit of HRT, has also been linked to a reduced risk of Alzheimer’s. Experts advise women to discuss their hormone levels with healthcare providers. This step can help determine whether HRT is a suitable option for managing menopause and preventing inflammation-related conditions.

The findings suggest HRT could play a crucial role in protecting women’s brain health during and after menopause. By addressing inflammation and hormone imbalances, the therapy may reduce risks for serious diseases. Medical professionals continue to recommend personalised consultations to assess individual needs.